|
| | Preemptive () | Controls () | |
|
| Rates (%) of PUQE ≥ 11 in first 3 weeks of NVP | 4 (15.4%) () | 9 (39.13%) () | |
| AUC of PUQE × Time in 1st trimester (SD) | 6.38 (1.58) () | 6.11 (2.24) () | NS |
| NVP resolved before labor | 18/23 (78.2%) | 11/22 (50%) | <0.002 |
| Gest. age when NVP resolved (median wk) | 26 | 33 | 0.18 |
| Distribution of HG in previous versus this pregnancy* | | | |
| HG in previous pregnancy | 19 | 11 | 0.047* |
| HG in present pregnancy | 6 | 6 | |
| Mean daily dose of Diclectin {mg/kg (SD)} | 0.65 (0.23) | 0.56 (0.24) | 0.2 |
Mean gestational age (in weeks)
when NVP symptoms began (SD) | 5.30 (1.02) | 5.45 (1.88) | |
| Mean start of preemptive therapy (SD) | 3.8 (0.98) | | |
|